MannKind | Egenkapital Og Reserver



Equity Capital And Reserves Endring Dato
Adma Biologics USD 349.02M 117.13M 2024-12
Dynavax Technologies USD 596.8M 84.63M 2024-12
Eli Lilly USD 14.19B 47.9M 2024-12
Halozyme Therapeutics USD 363.82M 88.88M 2024-12
Insmed USD 285.38M 198.04M 2024-12
MacroGenics USD 116.06M 4.01M 2024-12
MannKind USD -78816000 131.11M 2024-12
Merck USD 46.31B 1.81B 2024-12
Novo Nordisk DKK 120.52B 8B 2024-09
Pfizer USD 88.2B 4.08B 2024-12
Sanofi 73B 1.36B 2024-06
Xencor USD 677.61M 46.22M 2024-12



MannKind Egenkapital Og Reserver - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Apr 2025.